About Biochrom
Biochrom is a company based in Cambridge (United Kingdom) founded in 1970 was acquired by Harvard Apparatus in March 1999. Biochrom offers products and services including Amino Acid Analyzers, UV/Visible Spectrophotometers, Microvolume Spectrophotometers, Colorimeters, and Cell Density Meters. Biochrom operates in a competitive market with competitors including Quanterix, Biocare Medical, Merck, Neogen and Parse Biosciences, among others.
- Headquarter Cambridge, United Kingdom
- SectorsHealthcare
- Email••••••••
- Website biochrom.co.uk
- Social LinkedIn X Facebook YouTube
- Acquired by Harvard Apparatus (Mar 1999)
- Legal Name Biochrom Limited
- Date of Incorporation 13 Mar, 1998
- Jurisdiction CAMBRIDGE, ENGLAND
- Investors
- Acquired byHarvard Apparatus
(Mar 1999)
Products & Services of Biochrom
Biochrom offers a comprehensive portfolio of products and services, including Amino Acid Analyzers, UV/Visible Spectrophotometers, Microvolume Spectrophotometers, Colorimeters, and Cell Density Meters.
Systems for analyzing amino acids in biological samples.
Instruments for measuring light absorption in research samples.
Devices for analyzing small volumes of scientific samples.
Tools for measuring color and density in lab applications.
Meters for assessing cell concentration in biological studies.
Apps and channels of Biochrom
its YouTube channel Harvard Bioscience has 390 subscribers and 30 videos.
Videos from Biochrom
The most watched videos on Biochrom's YouTube channel, Harvard Bioscience (390 subscribers). Click a video to play it here.
More on Harvard Bioscience.
Investors in Biochrom
Biochrom has secured backing from 1 investor. Prominent investors backing the company include Harvard Apparatus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Harvard Apparatus is recognized as a manufacturer of specialized physiological research equipment. | 1901 | harvardapparatus.com | Holliston, United States |
Investor details for Biochrom
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Biochrom
2 dated milestones of Biochrom across 29 years, from founding to its latest funding, stage changes and deals.
- Founded Biochrom is founded.
- Exit Acquired by Harvard Apparatus.
Competitors of Biochrom
Biochrom operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Quanterix, Biocare Medical, Merck, Neogen and Parse Biosciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| quanterix.com | 2007 | Cambridge, United States | $99.5M | 141 | Assay kits for ultra-sensitive biomarker detection are developed. | |
| biocare.net | 1997 | Concord, United States | $85M | 161 | Primary antibodies and instruments for immunohistochemistry are manufactured. | |
| merckgroup.com | 1668 | Darmstadt, Germany | – | 922 | Merck is engaged in science and technology solutions globally. | |
| neogen.com | 1982 | Lansing, United States | $700,000 | 2,640 | Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing | |
| parsebiosciences.com | 2018 | Seattle, United States | $100.26M | – | RNA-sequencing transcriptome kits for health data analysis are developed. | |
| biolifesolutions.com | 1987 | Bothell, United States | – | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | |
| telesisbio.com | 2013 | San Diego, United States | $25M | – | Online platform offering life sciences reagents and kits | |
| qiagen.com | 1984 | Hilden, Germany | – | 104 | Products and reagents for molecular diagnostic assays are supplied. | |
| bio-rad.com | 1952 | Hercules, United States | – | 10 | Portfolio of products and services for life science research and clinical diagnostic markets |
Detailed competitors of Biochrom
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Biochrom
Websites that share an audience with Biochrom (biochrom.co.uk).
Websites whose visitors overlap most with Biochrom. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
elementar.de | elementar.de | 100% | – | – | – |
| selectech.co.za | 73% | – | #5,136,501 | View details | |
shellab.com | shellab.com | 72% | – | #10,800,808 | – |
promega.com | promega.com | 72% | – | #192,389 | – |
coylab.com | coylab.com | 72% | – | #3,150,674 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for Biochrom
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Biochrom
10 companies that operate in the same segment as Biochrom (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biochrom
Biochrom was founded in 1970.
Biochrom is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Biochrom was established in 1970 in Cambridge, United Kingdom, within the scientific instrumentation sector. A range of products is manufactured, including UVVis spectrophotometers, micro-volume kits for DNA, RNA, oligos, and protein quantification, amino acid analyzers, and microplate readers with washers. Technical support and consulting services are offered to clients across various applications. Operations focus on precision measurement tools for laboratory use.
Biochrom's top competitors include Neogen, Biocare Medical and Merck.
Biochrom offers Amino Acid Analyzers, UV/Visible Spectrophotometers, Microvolume Spectrophotometers, Colorimeters, and Cell Density Meters.
Biochrom has 1 investor. Key investors include Harvard Apparatus.
Biochrom operates through Biochrom Limited.
Yes. Biochrom was acquired by Harvard Apparatus in March 1999.